Three novel benzothiazine-fused triazoles as potential centrally acting muscle relaxants

The structures of the novel triazolobenzothiazines 2,4‐dihydro‐1H‐benzo[b][1,2,4]triazolo[4,3‐d][1,4]thiazin‐1‐one (IDPH‐791), C9H7N3OS, (I), a potential muscle relaxant, its benzoyl derivative, 2‐(2‐oxo‐2‐phenylethyl)‐2,4‐dihydro‐1H‐benzo[b][1,2,4]triazolo[4,3‐d][1,4]thiazin‐1‐one, C20H17N3O4S, (II), and the β‐keto ester derivative, ethyl 3‐oxo‐2‐(1‐oxo‐2,4‐dihydro‐1H‐benzo[b][1,2,4]triazolo[4,3‐d][1,4]thiazin‐2‐yl)‐3‐phenylpropanoate, C17H13N3O2S, (III), are the first examples of benzothiazine‐fused triazoles in the crystallographic literature. The heterocyclic thiazine rings in all three structures adopt a distorted half‐chair conformation. Compound (III) exists in the trans‐β‐diketo form. Other than N—H...O hydrogen bonds in (I) forming dimers, no formal intermolecular hydrogen bonds are involved in the crystal packing of any of the three structures, which is dominated by C—H...O/N and π–π stacking interactions.